KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Receivables (2016 - 2025)

Charles River Laboratories International has reported Receivables over the past 17 years, most recently at $719.3 million for Q4 2025.

  • For Q4 2025, Receivables changed 0.22% year-over-year to $719.3 million; the TTM value through Dec 2025 reached $719.3 million, changed 0.22%, while the annual FY2025 figure was $719.3 million, 0.22% changed from the prior year.
  • Receivables for Q4 2025 was $719.3 million at Charles River Laboratories International, down from $748.3 million in the prior quarter.
  • Over five years, Receivables peaked at $818.7 million in Q3 2023 and troughed at $610.6 million in Q1 2021.
  • A 5-year average of $742.4 million and a median of $755.4 million in 2024 define the central range for Receivables.
  • Biggest five-year swings in Receivables: increased 22.35% in 2021 and later fell 10.57% in 2024.
  • Year by year, Receivables stood at $657.6 million in 2021, then grew by 14.42% to $752.4 million in 2022, then rose by 7.14% to $806.1 million in 2023, then fell by 10.57% to $720.9 million in 2024, then dropped by 0.22% to $719.3 million in 2025.
  • Business Quant data shows Receivables for CRL at $719.3 million in Q4 2025, $748.3 million in Q3 2025, and $780.4 million in Q2 2025.